中恒集团：9月12日召开董事会会议

Group 1 - The core point of the article is that Zhongheng Group announced the convening of its 2025 second extraordinary general meeting of shareholders during its board meeting held on September 12, 2025 [1] - For the fiscal year 2024, Zhongheng Group's revenue composition is as follows: 76.26% from pharmaceutical manufacturing, 13.84% from other businesses, and 9.9% from food [1] - As of the time of reporting, Zhongheng Group has a market capitalization of 8.9 billion yuan [1]